Identification and validation of reference genes of circulating microRNAs for use as control in gestational

Ingrid de Siqueira Pereira1, Allecineia Bispo da Cruz1, Marta Marques Maia1

  • 1Centro de Parasitologia e Micologia, Instituto Adolfo Lutz, Sao Paulo, Brazil; Programa de Pós-Graduação em Ciências da Coordenadoria de Controle de Doenças da Secretaria de Estado da Saúde de São Paulo, Brazil.

Insights

This study identified miR-484 as a stable endogenous reference gene for quantifying microRNAs in gestational toxoplasmosis (GT) plasma samples. This finding supports accurate biomarker development for diagnosing and monitoring fetal toxoplasmosis.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Genetics

Background:

  • Gestational toxoplasmosis (GT) poses significant fetal risks due to parasite dissemination.
  • Circulating microRNAs (miRNAs) show promise as diagnostic and prognostic biomarkers.
  • Accurate miRNA quantification requires reliable endogenous reference genes for normalization in quantitative real-time PCR (qPCR).

Purpose of the Study:

  • To evaluate the stability of three endogenous miRNAs (miR-484, miR-423-3p, miR-26b-5p) as normalizers for miRNA expression studies in gestational toxoplasmosis.
  • To identify the most stable miRNA for accurate quantification in clinical samples.

Main Methods:

  • Analysis of plasma samples from 21 women with GT and 11 healthy controls.
  • Evaluation of miRNA stability using RefFinder algorithm, incorporating GeNorm, Normfinder, BestKeeper, and comparative delta-CT methods.
  • Quantitative real-time PCR (qPCR) for miRNA expression analysis.

Main Results:

  • miR-484 demonstrated the highest stability among the tested endogenous miRNAs.
  • miR-484 exhibited equivalent expression levels in both gestational toxoplasmosis and normal control groups.
  • The stability of miR-484 was confirmed across multiple analytical algorithms.

Conclusions:

  • miR-484 is a suitable and stable endogenous reference gene for normalizing miRNA expression in plasma samples from women with gestational toxoplasmosis.
  • This finding facilitates future research on miRNA biomarkers for GT diagnosis and prognosis.
  • Validated normalization strategies are crucial for reliable clinical applications of circulating miRNAs.